Gilead Sciences Inc. (NASDAQ: GILD) has announced it will be taking over HOOKIPA Pharma Inc. (NASDAQ: HOOK) for a consideration of $10 million.

Gilead Sciences is laying off 36 people as part of a rethink that saw the Big Pharma scrap plans to expand a biologics facility in California. At one point, the company had been planning to expand ...

Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, has been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for ...

Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including those for reducing HIV risk and ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.

AHF: Gilead’s Greed Kills Promise of Lenacapavir for HIV PreventionLUBLIN, Poland-- (BUSINESS WIRE)--Join AIDS Healthcare Foundation (AHF) Poland for a Menstrual Health Day commemorative event ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.